Remdesivir Active Not Recruiting Phase 3 Trials for Coronavirus Disease 2019 (COVID‑19) Treatment

Indications	Status	Purpose	Phase
DBCOND0129755 (Coronavirus Disease 2019 (COVID‑19))	Active Not Recruiting	Treatment	3

clinicaltrials.gov Identifier	Title	Drugs
NCT04501978	ACTIV-3: Therapeutics for Inpatients With COVID-19	AZD7442 (DB15787) Bamlanivimab (DB15718) Cilgavimab (DB16393) PF-07304814 (DB16514) Remdesivir (DB14761) Sotrovimab (DB16355) Tixagevimab (DB16394)
NCT04593940	Immune Modulators for Treating COVID-19	Abatacept (DB01281) Cenicriviroc (DB11758) Infliximab (DB00065) Remdesivir (DB14761)
NCT04610541	REMdesivir-HU Clinical Study and Severe Covid-19 Patients	Remdesivir (DB14761)